If this message is not displayed correctly, click here.


No 118, December 2017


A new educational resource on nutrition management in dialysis patients is available on COMPACT RENAL (click here), an educational platform funded by Vifor Fresenius Medical Care Renal Pharma. This downloadable presentation addresses the challenges of balancing phosphate levels and protein intake, including in the growing elderly dialysis population. It also suggests an integrated approach to achieve phosphate control in CKD. This presentation was developed in association with Prof. Denis Fouque (France). 

The Clinical Transplantation Day (CTDay) 2017 Webcast is published on ENP now!

The CTDay 2017 was a successful educational event on Kidney and Liver Transplantation that took place on December 6, 2017 in Parma (Italy) and that was endorsed by Descartes (one of ERA-EDTA Working Groups) and EKITA (an ESOT Working Group). The course focused on “Optimizing Prophylaxis of Kidney and Liver Transplant Rejection”. The webcast and slide presentations (in PDF format) shown at CTDay 2017 are now available on ENP for all registered users, ERA-EDTA, DESCARTES and ESOT members.

Click here to view the webcast.

Vltava River and Charles Bridge - Prague

Vltava River and Charles Bridge - Prague

Get ready for the ERA-EDTA’s 2018 Educational Programme!

The ERA-EDTA Committee for CME activities, chaired by Prof. Loreto Gesualdo, is proud to announce that the ERA-EDTA educational programme for the first semester of 2018 is now online. Click here to read it.


One of the first CMEs of 2018 is the educational event organized by Prof. Ivan Rychlik, traditionally held during the 18th Prague Postgraduate Training Course under the auspices of the Czech Society of Nephrology. This year the CME will focus on ‘Growing spectrum of treatment options in ESRD’. Click here to learn more about the scientific program and travel grant opportunities.

NDT and CKJ articles

Just published online: read the latest NDT and CKJ articles

A plea for optimizing hypertension in renal transplant recipients

The rate of cardiovascular problems is high in patients who received a kidney transplant. Besides, the risk for progressive graft loss and renal complications is high, too. Everyone knows that hypertension is a risk factor for CV events, but what is rather unknown is that it is also the number one of non-immunological risk factor for graft loss. Therefore, it is vital to control and, if necessary, to lower blood pressure in kidney transplant patients. However, accurate diagnosis, treatment and monitoring remains suboptimal in this patient population – and this is the reason why the authors of this editorial, freshly published in NDT, call for action.

Halimi et al. admit, though, that hypertension in renal transplantation is often difficult to treat – and that there are controversies regarding the choice of antihypertensive medication. Therefore, the authors conclude that research in this area is needed: Hypertension is an important risk factor – and it is a modifiable one!

A 30-year follow-up on Bartter and Gitelman syndromes

Bartter and Gitelman syndromes are autosomal recessive disorders involving renal electrolyte losses. Due to their rare occurrence, very few data are available on prognosis and therapeutic management. The study published in CKJ presents data for 45 children with various genetic mutations, with a median follow-up of just under nine years (1984–2014).

Fractional excretion of chloride prior to therapy was greater than 0.5% in all patients; children with CLCNKB mutation had the lowest serum potassium and serum magnesium levels and the highest bicrabonate levels. An increased incidence of prematurity after polyhydramnios was found among children with SLC12A1 and KCNJ1 mutations. Patients with these mutations had nephrocalcinosis at presentation in most cases and impaired renal function at the last follow-up (71 and 62 ml/min/1.73 m2, respectively).

In summary, the children had a satisfactory prognosis, in summary. They all showed impairment of growth, but not to a significant degree (-1.2 SD). The frequencies of proteinuria (31/45 children), impaired GFR and electrolyte abnormalities show the need to monitor glomerular and tubular function on a regular basis. Electrolyte supplementation is necessary to counteract renal salt loss.


European Renal Best Practice (ERBP) new Advisory Board member - Prof. Dr Sevcan A. Bakkaloglu

The Advisory Board of the European Renal Best Practice (ERBP) is pleased to announce that Prof. Dr Sevcan A. Bakkaloglu from Gazi University (Turkey) has been appointed as a new member of the ERBP Board following an open call for a pediatric nephrologist.

ERBP's mission is to improve the outcome of patients with kidney disease in a sustainable way, through enhancing the accessibility of knowledge on patient care, in a format that stimulates its use in clinical practice. The ERBP Advisory Board believes that Prof. Bakkaloglu will be a great asset in continuing to achieve this mission.

ERA-EDTA: Innovation and Education in Kidney Science and Care.
Web Site

ERA-EDTA Flash is the official ERA-EDTA eNewsletter

Editor-in-Chief: Mustafa Arici
Editorial Secretariat: Valentina Cocchi
Newsletter Design: Ilaria Martini

ERA-EDTA Headquarters
Via XXIV Maggio, 38
43123 Parma - Italy


The ERA-EDTA collects and processes personal information to provide you with details regarding the Association and its activities. The information is used for accounting and commercial purposes by ERA-EDTA and/or Euromeetings s.r.l. in compliance with the Italian Legislative Decree 196/2003.